Corbus Receives Orphan Designation for JBT-101 for the Treatment of Systemic Sclerosis in the European Union Pharmaceutical Investing
BioPharmX Data Suggest Anti-Inflammatory Activity of BPX-01 Topical Minocycline Gel Life Science Investing
Hemispherx Biopharma Announces Extension of Rintatolimod European Early Access Program (EAP) to Pancreatic Cancer Patients Pharmaceutical Investing
PetLife Pharmaceuticals reports the First of Three Preclinical Studies in their pre-INAD Process for Vitalzul.  Blue Scorpion Venom Toxicity Study Results Show No Adverse Reactions across Multiple Dosing Levels. Pharmaceutical Investing
Coherus BioSciences Announces Positive Topline 24-Week Treatment Phase Three Results for CHS-1420 (HUMIRA® Biosimilar Candidate) in Patients with Psoriasis Pharmaceutical Investing
BioCryst Receives Health Canada Approval for RAPIVAB® for the Treatment of Influenza Life Science Investing
